Filing Details

Accession Number:
0001209191-17-031435
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-11 10:29:18
Reporting Period:
2017-05-11
Filing Date:
2017-05-11
Accepted Time:
2017-05-11 10:29:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1000694 Novavax Inc NVAX Biological Products, (No Disgnostic Substances) (2836) 222816046
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1342826 C Stanley Erck C/O Novavax, Inc.
20 Firstfield Road
Gaithersburg MD 20878
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-11 50,000 $0.84 128,279 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8266 to $0.8399, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.